Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001550350-15-000001
Filing Date
2015-10-01
Accepted
2015-10-01 12:16:35
Documents
1
Effectiveness Date
2015-10-01
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 11563
  Complete submission text file 0001550350-15-000001.txt   12625
Mailing Address 4320 FOREST PARK AVENUE, SUITE 303 ST. LOUIS MO 63108
Business Address 4320 FOREST PARK AVENUE, SUITE 303 ST. LOUIS MO 63108 (314) 604-2850
Euclises Pharmaceuticals, Inc. (Filer) CIK: 0001550350 (see all company filings)

EIN.: 452840488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-209852 | Film No.: 151136184